Novo Nordisk A/S

(PINK:NONOF)

Latest On Novo Nordisk A/S (NONOF):

Date/Time Type Description Signal Details
2021-03-26 05:57 ESTDividendA dividend of $5.85 has been announced on Nov 30, -0001. It will be paid Mar 30, 2021 with an ex-dividend date of Mar 26, 2021.Neutral
2021-02-22 12:01 ESTNewsObesity Offers Tremendous Potential For Novo NordiskN/A
2021-02-05 21:04 ESTFinancialsCompany financials have been released.Neutral
2021-02-04 04:27 ESTNewsNovo Nordisk A/S 2020 Q4 - Results - Earnings Call PresentationN/A
2021-02-04 04:26 ESTNewsNovo Nordisk A/S (NVO) CEO Lars Jørgensen on Q4 2020 Results - Earnings Call TranscriptN/A
2021-01-19 19:59 ESTNewsNovo Nordisk: An Outstanding Company For The Long TermN/A
2021-01-12 15:57 ESTNewsNovo Nordisk A/S (NVO) CEO Lars Jørgensen Presents at 39th Annual JPMorgan Virtual Healthcare Conference (Transcript)N/A
2020-12-08 15:23 ESTNewsNovo Nordisk A/S's (NVO) CEO Lars Jørgensen on ESG Conference Call - TranscriptN/A
2020-12-02 08:09 ESTNewsNovo Nordisk (NVO) Presents At ESG Conference- SlideshowN/A
2020-12-02 08:08 ESTNewsNovo Nordisk A/S (NVO) CEO Lars Jørgensen on ESG Conference Call - TranscriptN/A
2020-11-26 22:14 ESTFinancialsCompany financials have been released.Neutral
2020-11-08 01:25 ESTFinancialsCompany financials have been released.Neutral
2020-11-07 17:41 ESTFinancialsCompany financials have been released.Neutral
2020-11-07 13:15 ESTFinancialsCompany financials have been released.Neutral
2020-11-01 06:13 ESTNewsNovo Nordisk A/S 2020 Q3 - Results - Earnings Call PresentationN/A
2020-11-01 06:12 ESTNewsNovo Nordisk A/S (NVO) CEO Lars Fruergaard Jorgensen on Q3 2020 Results - Earnings Call TranscriptN/A
2020-09-26 14:41 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 06:46 ESTFinancialsCompany financials have been released.Neutral
2020-08-14 10:41 ESTFinancialsCompany financials have been released.Neutral
2020-08-07 18:13 ESTFinancialsCompany financials have been released.Neutral
2020-08-07 05:52 ESTNewsNovo Nordisk A/S 2020 Q2 - Results - Earnings Call PresentationN/A
2020-08-07 05:49 ESTNewsNovo Nordisk A/S (NVO) CEO Lars Fruergaard Jorgensen on Q2 2020 Results - Earnings Call TranscriptN/A
2020-08-06 10:02 ESTFinancialsCompany financials have been released.Neutral
2020-07-30 18:26 ESTFinancialsCompany financials have been released.Neutral
2020-07-30 06:23 ESTFinancialsCompany financials have been released.Neutral
2020-07-29 22:33 ESTFinancialsCompany financials have been released.Neutral
2020-07-27 14:17 ESTFinancialsCompany financials have been released.Neutral
2020-07-23 19:01 ESTFinancialsCompany financials have been released.Neutral
2020-07-09 10:31 ESTFinancialsCompany financials have been released.Neutral
2020-07-01 18:16 ESTFinancialsCompany financials have been released.Neutral
2020-06-19 14:10 ESTFinancialsCompany financials have been released.Neutral
2020-06-14 06:14 ESTFinancialsCompany financials have been released.Neutral
2020-06-12 07:47 ESTFinancialsCompany financials have been released.Neutral
2020-05-27 06:50 ESTFinancialsCompany financials have been released.Neutral
2020-05-25 17:03 ESTNewsNovo Nordisk: Continuing To Shine Despite The PandemicN/A
2020-05-21 02:23 ESTFinancialsCompany financials have been released.Neutral
2020-05-13 22:01 ESTNewsNovo Nordisk And COVID-19: As If Nothing HappenedN/A
2020-05-10 00:51 ESTNewsNovo Nordisk A/S (NVO) on Q1 2020 Results - Earnings Call TranscriptN/A
2020-05-08 18:06 ESTFinancialsCompany financials have been released.Neutral
2020-05-07 16:01 ESTNewsNovo Nordisk A/S 2020 Q1 - Results - Earnings Call PresentationN/A
2020-05-06 06:59 ESTFinancialsCompany financials have been released.Neutral
2020-04-26 09:51 ESTFinancialsCompany financials have been released.Neutral
2020-04-03 22:24 ESTFinancialsCompany financials have been released.Neutral
2020-03-27 06:00 ESTDividendA dividend of $5.35 has been announced on N/A. It will be paid Mar 31, 2020 with an ex-dividend date of Mar 27, 2020.Neutral
2020-03-25 21:57 ESTFinancialsCompany financials have been released.Neutral
2020-02-28 05:30 ESTFinancialsCompany financials have been released.Neutral
2020-02-27 23:34 ESTFinancialsCompany financials have been released.Neutral
2020-02-22 01:10 ESTFinancialsCompany financials have been released.Neutral
2020-02-21 00:39 ESTFinancialsCompany financials have been released.Neutral
2020-02-18 00:55 ESTFinancialsCompany financials have been released.Neutral

About Novo Nordisk A/S (NONOF):

Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Lund University to develop treatment for Parkinson's diseases; and bluebird bio, Inc. to develop genome editing treatments for children and adult patients. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

See Advanced Chart

General

  • Name Novo Nordisk A/S
  • Symbol NONOF
  • Type Common Stock
  • Exchange PINK
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 44,723
  • Last Split Factor5:1
  • Last Split Date2014-01-02
  • Fiscal Year EndDecember
  • Web URLhttp://www.novonordisk.com
View More

Valuation

  • Trailing PE 28.53
  • Forward PE 23.92
  • Price/Sales (Trailing 12 Mt.) 8.35
  • Price/Book (Most Recent Quarter) 16.51
  • Enterprise Value Revenue 1.29
  • Enterprise Value EBITDA 2.77
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Profit Margin 33%
  • Return on Assets 25%
  • Return on Equity 70%
  • Earnings Per Share $2.46
  • Revenue Per Share $0
  • Gross Profit 106.01 billion
  • Quarterly Earnings Growth -0.9%
View More

ESG Rating

  • Rating Date 2019-01-01
  • ESG Score 21.83
  • Environment Score 0.84
  • Social Score 10.95
  • Governance Score 9.21
  • Controversy Level 3
View More

Highlights

  • Market Capitalization 159.3 billion
  • PEG Ratio 3.55
  • Book Value Per Share $3.08
View More

Share Statistics

  • Shares Outstanding 1.77 billion
  • Shares Float 1.65 billion
  • % Held by Insiders <1%
  • % Held by Institutions 31.84%
View More

Technicals

  • Beta 0.29
  • 52 Week High $77.4
  • 52 Week Low $47.3
  • 50 Day Moving Average 72.08
  • 200 Day Moving Average 70.02
View More

Dividends

  • Forward Annual Dividend Rate $1.91
  • Forward Annual Dividend Yield 2.63%
  • Payout Ratio 84%
  • Dividend Date 2018-03-27
  • ExDividend Date 2021-03-26
  • Dividend Per Share $1.23
  • Dividend Yield 0%
View More

Novo Nordisk A/S (NONOF) Dividend Calendar:

NONOF's last dividend payment was made to shareholders on March 27, 2018.
Novo Nordisk A/S pays out 84% of its earnings out as a dividend.

Ex-Dividend Date Payment Date Record Date Declared Date Amount
2021-03-262021-03-302021-03-290000-00-00$5.85
2020-08-142020-08-182020-08-172020-08-18$3.25
2020-03-272020-03-312020-03-30$5.35
2019-08-162019-08-202019-08-19$3
2019-03-222019-03-262019-03-25$5.15
2018-08-172018-08-282018-08-202018-08-07$3
2018-03-232018-03-272018-03-26$4.85
2017-08-182017-08-222017-08-212017-08-10$3
2017-03-242017-03-282017-03-270000-00-00$4.6
2016-08-122016-08-162016-08-152016-08-05$3
2016-03-212016-03-232016-03-222016-02-03$6.4

Novo Nordisk A/S (NONOF) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.

NONOF's next estimated earnings release date is June 30, 2021.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312020-12-31$32.14 billion$0.64
2020-09-302020-12-31$N/A$0.66
2020-06-302020-09-30$N/A$0.70$4.33-83.93%
2020-03-312020-06-30$33.88 billion$0.68$4.68-85.41%
2019-12-312020-03-31$32.42 billion$0.75$3.81-80.41%
2019-09-302019-12-31$30.28 billion$0.55$4.12-86.53%
2019-06-302019-09-30$30.04 billion$0.63$4.04-84.5%
2019-03-312019-06-30$29.29 billion$0.61$4.09-84.99%
2018-12-312019-03-31$29.73 billion$0.66$3.71-82.34%
2018-09-302018-12-31$27.76 billion$0.54$3.91-86.17%
2018-06-302018-09-30$27.41 billion$0.58$4.16-86%
2018-03-312018-06-30$26.93 billion$0.67$4.10-83.71%
2017-12-312018-03-31$27.99 billion$0.73$3.51-79.28%
2017-09-302017-12-31$26.61 billion$0.54$3.80-85.76%
2017-06-302017-09-30$37.3 billion$0.63$3.87-83.75%
2017-03-312017-06-30$28.45 billion$0.62$3.64-83.08%
2016-12-312017-03-31$0.58$3.53-83.5%
2016-09-302016-12-31$0.49$3.76-86.98%
2016-06-302016-09-30$0.58$3.90-85.03%
2016-03-312016-06-30$0.59$3.62-83.84%
2015-12-312016-03-31$0.57$3.34-83.02%
2015-09-302015-12-31$0.47$3.29-85.73%
2015-06-302015-09-30$0.49$3.19-84.71%
2015-03-312015-06-30$0.48$3.31-85.43%
2014-12-312015-03-31$0.55$2.47-77.94%
2014-09-302014-12-31$0.41$2.60-84.31%
2014-06-302014-09-30$0.42
2014-03-312014-06-30$0.49
2013-12-312014-03-31$0.45
2013-09-302013-12-31$0.42
2013-06-302013-09-30$0.43
2013-03-312013-06-30$0.43
2012-12-312013-03-31$0.38
2012-09-302012-12-31$0.37
2012-06-302012-09-30$0.36
2012-03-312012-06-30$0.33
2011-12-312012-03-31$0.30
2011-09-302011-12-31$0.29
2011-06-302011-09-30$0.27
2011-03-312011-06-30$0.28
2010-12-312011-03-31$0.27
2010-09-302010-12-31$0.25
2010-06-302010-06-30$0.21
2010-03-312010-03-31$0.21
2009-12-312009-12-31$0.15
2009-09-302009-09-30$0.18
2009-06-302009-06-30$0.18
2009-03-312009-03-31$0.15
2008-12-312008-12-31$0.13
2008-09-302008-09-30$0.17
2008-06-302008-06-30$0.17
2008-03-312008-03-31$0.14
2005-12-312005-12-31$0.06

Novo Nordisk A/S (NONOF) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Novo Nordisk A/S (NONOF) Chart:

Novo Nordisk A/S (NONOF) News:

Below you will find a list of latest news for Novo Nordisk A/S (NONOF) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Novo Nordisk A/S (NONOF) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Novo Nordisk A/S (NONOF) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link